Patrick Round

Patrick Round is an accomplished professional in the biotechnology and pharmaceutical sectors with extensive experience in leadership roles. Currently serving as Chief Medical Officer at Istesso, Patrick also holds the position of Venture Partner at Forbion Capital Partners. With a long-standing tenure as Chief Executive Officer and Chief Medical Officer at Xention Limited since 2009, Patrick oversees all preclinical, clinical, and manufacturing development projects utilizing a virtual model. In addition to independent consulting through Patrick Round Consulting, Patrick has held significant roles such as Medical Director at Staten Biotechnology B.V., Project Physician at Mission Therapeutics, and Chief Medical Officer at Citryll B.V. and NorthSea Therapeutics BV. Previous experience includes a leadership role at Cambridge Antibody Technology, overseeing a diverse team in development functions. Patrick earned a degree in Medicine (MBBS) from Charing Cross Hospital Medical School.